| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17,123 |
14,369 |
$1.21M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,159 |
7,132 |
$396K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,014 |
2,241 |
$251K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,692 |
1,557 |
$176K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
14,052 |
12,473 |
$170K |
| 59425 |
|
1,358 |
1,024 |
$125K |
| 59426 |
|
1,543 |
572 |
$122K |
| 99382 |
|
1,165 |
1,086 |
$120K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
872 |
765 |
$88K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
727 |
655 |
$77K |
| D0999 |
Unspecified diagnostic procedure, by report |
1,025 |
797 |
$35K |
| 99384 |
|
347 |
280 |
$31K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
204 |
192 |
$22K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
177 |
171 |
$19K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
127 |
119 |
$13K |
| D0140 |
Limited oral evaluation - problem focused |
437 |
401 |
$13K |
| D1120 |
Prophylaxis - child |
190 |
160 |
$10K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
249 |
156 |
$10K |
| 83655 |
|
1,318 |
1,242 |
$7K |
| 99383 |
|
53 |
53 |
$6K |
| 99201 |
|
28 |
27 |
$3K |
| 99381 |
|
30 |
28 |
$3K |
| 59025 |
Fetal non-stress test |
114 |
77 |
$3K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
16 |
12 |
$2K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
524 |
405 |
$733.31 |
| 0001A |
|
149 |
77 |
$717.40 |
| 0002A |
|
136 |
65 |
$681.53 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
23 |
12 |
$670.60 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
4,216 |
3,908 |
$569.30 |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
36 |
36 |
$469.35 |
| 0011A |
|
54 |
31 |
$322.83 |
| D1206 |
Topical application of fluoride varnish |
186 |
154 |
$253.38 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
655 |
462 |
$231.38 |
| 90686 |
|
1,210 |
1,050 |
$133.10 |
| 90670 |
|
741 |
683 |
$115.25 |
| 90734 |
|
393 |
376 |
$115.25 |
| G0008 |
Administration of influenza virus vaccine |
515 |
488 |
$78.40 |
| 0071A |
|
12 |
12 |
$71.74 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
110 |
106 |
$66.49 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$8.79 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
23 |
15 |
$7.68 |
| 90677 |
|
95 |
56 |
$0.09 |
| 90633 |
|
732 |
665 |
$0.06 |
| 90696 |
|
229 |
198 |
$0.04 |
| 3074F |
|
341 |
277 |
$0.00 |
| 3008F |
|
5,382 |
4,458 |
$0.00 |
| 3079F |
|
290 |
223 |
$0.00 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
457 |
438 |
$0.00 |
| 90647 |
|
587 |
539 |
$0.00 |
| 90723 |
|
515 |
470 |
$0.00 |
| 85018 |
|
1,520 |
1,438 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,451 |
4,757 |
$0.00 |
| 1126F |
|
216 |
198 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
116 |
109 |
$0.00 |
| 90651 |
|
540 |
503 |
$0.00 |
| 90716 |
|
581 |
534 |
$0.00 |
| 92551 |
|
1,628 |
1,486 |
$0.00 |
| 3351F |
|
642 |
463 |
$0.00 |
| 87081 |
|
81 |
76 |
$0.00 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
126 |
119 |
$0.00 |
| 3080F |
|
41 |
38 |
$0.00 |
| 90697 |
|
53 |
25 |
$0.00 |
| 97802 |
|
160 |
127 |
$0.00 |
| D1330 |
|
71 |
64 |
$0.00 |
| 90656 |
|
85 |
72 |
$0.00 |
| 91301 |
|
64 |
38 |
$0.00 |
| 1125F |
|
71 |
46 |
$0.00 |
| 86592 |
|
114 |
107 |
$0.00 |
| 3075F |
|
27 |
16 |
$0.00 |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
33 |
32 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
22 |
20 |
$0.00 |
| 90700 |
|
38 |
38 |
$0.00 |
| 1160F |
|
3,238 |
2,702 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,468 |
3,052 |
$0.00 |
| 1159F |
|
4,078 |
3,304 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
130 |
121 |
$0.00 |
| D0190 |
|
243 |
148 |
$0.00 |
| 99173 |
|
1,628 |
1,486 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
66 |
56 |
$0.00 |
| 90715 |
|
425 |
398 |
$0.00 |
| 86703 |
|
13 |
13 |
$0.00 |
| 90707 |
|
419 |
379 |
$0.00 |
| 3078F |
|
245 |
194 |
$0.00 |
| 0502F |
|
782 |
439 |
$0.00 |
| 90681 |
|
224 |
194 |
$0.00 |
| 3077F |
|
172 |
147 |
$0.00 |
| 90658 |
|
26 |
26 |
$0.00 |
| 0013A |
|
14 |
14 |
$0.00 |
| 82948 |
|
14 |
12 |
$0.00 |
| 90685 |
|
22 |
14 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
22 |
22 |
$0.00 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
16 |
16 |
$0.00 |